Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization

R. B. Verheijen, L. E. Swart, J. H. Beijnen, J. H.M. Schellens, A. D.R. Huitema, N. Steeghs

Research output: Contribution to journalArticlepeer-review

51 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science